glp-1 drug class A schematic overview of receptor agonists: classification, GLP-1 receptor agonists | How

Phentermine and GLP-1 receptor agonists are distinct medications that work through different biological pathways to support weight loss

Primary care physicians often make decisions regarding the initiation of basal insulin in T2D, as they work closely with patients and are well placed to discuss and manage the transition to basal insulin therapy

Henney 2024) demonstrated a potentially meaningful reduction in incident pneumonia with GLP-1 RAs compared with dipeptidyl peptidase-4 (DPP-4) inhibitors (hazard ratio [HR] 0.60, 95% confidence interval [CI] 0.580.62

A National Institutes of Health (NIH)-funded study has found that an emerging class of GLP-1 weight loss drugs suppress eating for pleasure, or hedonic feeding, in mice by modulating a reward circuit deep within the brain

A Breakthrough Award, New Evidence in Parkinson's and Heart Disease

Gastrointestinal symptoms such as nausea, constipation, and indigestion are most common and usually subside as your body adjusts